Edison, NJ, United States of America

Pradeep B Madan

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1988-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Lake Hiawatha, NJ (US) (1988)
  • Edison, NJ (US) (1991)

Company Filing History:


Years Active: 1988-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pradeep B Madan: Innovator in Pharmaceutical Chemistry

Introduction

Pradeep B Madan is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on the development of compounds that have potential therapeutic applications.

Latest Patents

Madan's latest patents include a process for preparing glycidic acid esters. This process involves reacting specific compounds to produce intermediates that are useful in the production of thiazepin-4(5H)-ones. These compounds have been identified as calcium channel blockers, which can be beneficial in lowering blood pressure and treating ischemia. Another patent involves the phosphorylation of cyclic amides, leading to the production of imines that can form valuable pharmaceutical compounds through nucleophilic displacement.

Career Highlights

Pradeep B Madan is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His innovative work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Madan has collaborated with notable coworkers such as David L Coffen and Alan N Schwartz, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Pradeep B Madan's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new therapeutic agents that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…